Last updated - September 18, 2025

High Risk

i
1.8

2

User Score

1.4

Trust Score

2.0

Brand Score

OVERVIEW

About Cencora

Cencora disclosed a cyber incident exposing patient information, affecting at least 27 pharmaceutical and biotech clients. The breach involved personally identifiable information and protected health information, with ongoing reviews to determine the full scope.

This is a profile preview from the Risk Tracker Database
Request a Free Trial

CONNECTIONS AND RELATIONSHIP

CONTACT INFORMATION

LinkedIn
Carl Koeneman
CEO LinkedIn
Robert Mauch
LinkedIn
Cencora
Twitter
@CencoraGlobal
Instagram
@cencoraglobal
Facebook
@Cencora
Contact No.
+17274608159

FINANCIAL RISK AUDIT

For Consumers
For Consumers

High Risk

Based on the available data, we advise consumers to avoid this Company altogether.

This advisory is based on an aggregate risk score derived from OSINT, Adverse Media, Reviews, and Risk Factors identified in our research.

You are likely to be at great risk by engaging in any sort of consumer-related activity with this entity.

For Employees
For Employees

Medium Risk

Based on the available data, we advise employees to be mindful when considering or continuing work with this Company.

This advisory stems from a medium-risk score compiled from OSINT, Adverse Media, Reviews, and Risk Factors uncovered in our analysis.

Employment with this entity may involve moderate risks.

For Banks & Investors
For Banks & Investors

High Risk

Based on the available data, we urge investors and bankers to avoid financial involvement with this Company.

This advisory is informed by an aggregate risk score based on OSINT, Adverse Media, Reviews, and Risk Factors identified through our investigation.

Engaging in investment or lending activities with this entity poses a substantial risk to your financial interests.

ASSESSMENT OUTCOME
  • Safe to Onboard

  • Enhanced Due Diligence required

  • Do Not Onboard

RECOMMENDATIONS
  • Monitor adverse media every 6 months

  • File SAR (Suspicious Activity Report) is warranted

  • Escalation to compliance committee

  • None

Do you agree with this our assessment on Cencora?

OSINT DATA POINT

eyeimg

Former Name

Amerisource Bergen Corporation
eyeimg

CEO

Robert P. Mauch
eyeimg

CFO

James F. Cleary
eyeimg

Established

2001
eyeimg

Jurisdiction

Pennsylvania
eyeimg

Headquarters

Conshohocken
eyeimg

Location

USA
eyeimg

Industry

Pharmaceutical Distribution
eyeimg

Revenue

$262B
eyeimg

Employees

46,000
eyeimg

Major Shareholder

Vanguard Fiduciary Trust Co.
eyeimg

Key Partnership

Walgreens Boots Alliance
eyeimg

Market Capitalization

$45.4 Billion
eyeimg

U.S. Healthcare Solutions Revenue

$57.9 Billion
eyeimg

Acquisition

Retina Consultants of America
eyeimg

Funding

$500M Funding
eyeimg

Ongoing Lawsuit

Stockholder settlement
eyeimg

Healthcare Solutions Revenue

$10.1 Billion
eyeimg

Cyber Incident

Data breach
eyeimg

Data Breach Settlement

$40M
eyeimg

Opioid Directors Settlement

$111M
Load More

ENTERPRISE RISK ASSESSMENT (ERA)

Cencora has faced scrutiny for its role in the opioid crisis, with allegations of inadequate monitoring and distribution of controlled substances.

In 2022, Cencora, formerly AmerisourceBergen, settled for $6.1 billion as part of a nationwide opioid lawsuit, accused of failing to report suspicious orders of prescription painkillers.

Some employee reviews on platforms like Glassdoor report dissatisfaction with management, workload, and lack of career advancement opportunities at Cencora.

Cencora was fined $260 million by the DEA in 2018 for failing to flag suspicious opioid orders, as reported by various media outlets.

There have been no widely reported allegations of anti-competitive behavior directly tied to Cencora in major media sources.

текст вкладки 2
текст вкладки 3
текст вкладки 4

AML and KYC Assessment

Regulatory and Compliance Screening

  • Sanctions Matches
  • Yes
  • No
  • Unclear
  • PEP Status
  • Yes
  • No
  • Unclear
  • Watchlist: (Interpol, EU, UN, OFAC, etc).
  • Yes
  • No
  • Unclear
  • Law Enforcement Mentions
  • Yes
  • No
  • Unclear

Litigation and Legal Proceedings

  • Criminal Proceedings
  • Yes
  • No
  • Unclear
  • Regulatory Enforcement Actions: [SEC, FCA, SEBI, etc.]
  • Yes
  • No
  • Unclear
  • Ongoing Investigations
  • Yes
  • No
  • Unclear
  • Reputational and Adv
  • Yes
  • No
  • Unclear

Reputational and Adverse Media Risks

  • Negative Media Mentions
  • Yes
  • No
  • Unclear
  • Allegations / Scandals
  • Yes
  • No
  • Unclear
  • Social Media Red Flags
  • Yes
  • No
  • Unclear
  • Censorship Attempts [PR, Takedowns, DMCA Abuse, etc.]
  • Yes
  • No
  • Unclear

Geographic and Jurisdictional Risk

  • Country Risk Level
  • Yes
  • No
  • Unclear
  • High-Risk Sections [Crypto, Gambling, Arms, etc.]
  • Yes
  • No
  • Unclear
  • Offshore Jurisdictions Used [Panama, BVI, Cyprus, etc.]
  • Yes
  • No
  • Unclear

Want detailed data on Cencora?

What you see here scratches the surface

Request a Free Trial

Do you have insider information on Cencora?

We offer reward for actionable intel

Submit Anonymous Tip

RED FLAGS AND ADVERSE NEWS

coming

medium.com

Visit Link

Cencora suffered a February 2024 breach exposing patient names, DOB, addresses, health diagnoses and prescription data.

  • First Detected

    04/06/2025
  • Sentiment Analysis

    Negative
  • Reach

    <1000
  • POV

    Second Person
  • Risk Factor

    High
  • Type

    Legal
  • Traffic Source

    Website
  • SERP

    Top 30
  • Share of Voice

    20%
  • Primary Keyword

    Lawsuit
coming

healthcaredive.com

Visit Link

Cencora directors settled for $111M after accusations of ignoring opioid oversupply risks and failing to enforce controls.

  • First Detected

    18/08/2025
  • Sentiment Analysis

    Negative
  • Reach

    >1000
  • POV

    Third Person
  • Risk Factor

    High
  • Type

    News
  • Traffic Source

    Website
  • SERP

    Top 10
  • Share of Voice

    40%
  • Primary Keyword

    Allegation
coming

hipaajournal.com

Visit Link

Cencora settled a $40M class action after a 2024 cyberattack exposed 1.43M patients’ personal and health data.

  • First Detected

    11/08/2025
  • Sentiment Analysis

    Negative
  • Reach

    >1000
  • POV

    Third Person
  • Risk Factor

    High
  • Type

    News
  • Traffic Source

    Website
  • SERP

    Top 30
  • Share of Voice

    40%
  • Primary Keyword

    Lawsuit

Other Red-Flags and Adverse News

redflag
2025 Cencora directors settle for $111M over alleged opioid mismanagement and igno...
redflag
2023 A judge narrowed the U.S. lawsuit against Cencora over alleged failures to re...
redflag
2025 Cencora to pay $111M to resolve claims of neglecting opioid warning signs and...

Financial Profile for Cencora

Do you want to unlock a detailed Risk Assessment and audit report for Cencora?

greentick

Based on user engagement on this review profile, ProConsumer will decide to publish its Risk Audit report for public if a threshold engagement, traffic and user input is achieved.

  • Known Assets: [Real estate, investments, companies]

    greentick
  • Suspicious Transactions

    greentick
  • Liabilities: [Bankruptcies, defaults, debts]

    greentick
  • Wealth Sources: [Legitimate / Unclear / High-risk]

    greentick
  • Bank Relationships

    greentick
  • Bank Relationships

    greentick
  • Ultimate Beneficial Owner(s) (UBOs)

    greentick
  • Shareholding structure

    greentick
  • Associated entities & subsidiaries

    greentick
  • Offshore / shell company links

    greentick
  • Trusts / Nominee arrangements

    greentick
  • Business Model Assessment

    greentick
consrevbg

Consumer Reviews and Ratings for
Cencora

All comments are user-generated content and may not be verified. They represent the personal opinions of the public and should not be relied upon. These comments do not influence or determine our overall rating.

User Rating for Cencora

Cencora disclosed a cyber incident exposing patient information, affecting at least 27 pharmaceutical and biotech clients. The breach involved personally identifiable information and protected health information, with ongoing reviews to determine the full scope.

USER’S SCORE

2

Trust

1

Safety

2

Brand

2

Risk

3

Pros

  • greentick

    Highly experienced

  • greentick

    Well-recognized name

Cons

  • redcros

    Faced allegations of scamming others

  • redcros

    Allegedly sold fake silver

  • redcros

    Sued multiple times

  • redcros

    Unregulated industry

  • redcros

    Alarming number of complaints online

Leave feedback about this

  • Trust
  • Brand
  • Safety
  • Risk

PROS

+
Add Field

CONS

+
Add Field
Choose Image

  • author-default
  • Hannah Fuchs
    July 28, 2025 at 6:48 am

It’s crazy that his felony property damage charge was dropped due to insufficient direct evidence, yet he still faces ongoing DMCA and fraud investigations over a decade later. That legal leniency seems to have emboldened a pattern of suppression and self‑promotion. It’s like history repeating itself—first physical damage, now reputational.

Trust

1/5

Safety

2/5

Brand

2/5

Risk

3/5

Bull Investment UG (haftungsbeschränkt) is a German entrepreneurial company (UG) based in Wangen im Allgäu, registered under HRB 740156 at Amtsgericht Ulm. Founded in 2020 with €500 share capital, it focused on managing its own assets, investments in other companies, and real estate. In October 2022, the company was dissolved after an insolvency proceeding was dismissed due to insufficient assets.

XM Group, operating through entities like XM Global Limited (Belize), has been blocked by the Monetary Authority of Singapore (MAS), for offering unregulated leveraged foreign exchange and CFD trading services without a Capital Markets Services licence. XM Group, a Cyprus-based forex and CFD broker founded in 2009 and regulated by CySEC among others, is not authorised by MAS.

Silver Lining X, LLC is a U.S.-based consulting firm founded by Paul Silverberg, offering strategic planning, compliance, and business-solutions services to startups and established companies across sectors including finance, HR, governance, and growth. Silverberg has worked with public and private firms and holds legal and business experience.

Corps Capital Advisors is a Dallas-area multi-family office and registered investment advisory firm that provides comprehensive wealth management, investment advisory, and legacy planning services tailored to high-net-worth individuals and families

Gary Scheer LLC, through its associated entity Retirement Financial Advisors, LLC, was led by Gary Richard Scheer, who recommended and sold over $12M in unregistered securities to at least 50 investors from 2010 to 18, earning more than $600,000 in commissions. 6 of the 7 investments Scheer promoted were later determined to be fraudulent, including ties to major Ponzi...

Priority is referenced in online complaint forums as a business entity associated with customer disputes and dissatisfaction over services and financial dealings, with commenters alleging issues such as non-delivery of promised results and lack of responsiveness; these represent individual grievances shared on public platforms, not verified legal judgments or official determinations.

United Capital Management of Kansas is a financial advisory firm based in Salina, Kansas, offering investment and wealth management services. The firm is associated with Chad M. Koehn and is registered with FINRA for securities activities. Public records note its history of regulatory disclosures through affiliated professionals.

LendingClub, founded in 2006 as pioneer in peer-to-peer lending, grew rapidly and went public in 2014 with the largest tech IPO of that year. In 2016, the company faced major crisis when founder, CEO Renaud Laplanche resigned after an internal review revealed that employees had knowingly sold $22 million in loans that did not meet an investor’s criteria.

ZAR Capital Group, led by Zacharia Ali, markets itself as a global investment firm with multibillion-dollar smart city projects and international ventures. However, public records, court filings, and investor reports reveal a starkly different reality: unverifiable projects, unpaid judgments, legal evasion, and regulatory gaps.

Capital Max Group LLC is a Florida-based private lending and real estate financing firm that has been linked to multiple civil lawsuits alleging financing disputes, misrepresentation, and advance-fee related issues, resulting in increased reputational and due-diligence scrutiny.

Want your companies to be on this guide?

Yes, continue
stayinfosectionbg

Stay informed about suspicious business.

© 2025 Proconsumer. All rights reserved.